Net Cash Provided by (Used in) Operating Activities |
-457K |
USD |
-98.3% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
-82.5K |
USD |
|
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
-222K |
USD |
|
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Common Stock, Shares, Issued |
3.16M |
shares |
0% |
Q1 2023 |
Q1 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-762K |
USD |
-230% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
12K |
USD |
-94.1% |
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Valuation Allowance |
256K |
USD |
+274% |
Q4 2022 |
FY 2022 |
Cash and Cash Equivalents, Period Increase (Decrease) |
-231K |
USD |
-407% |
Q1 2022 |
Q1 2022 |
Deferred Tax Assets, Gross |
262K |
USD |
|
Q4 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
0 |
USD |
-100% |
Q4 2022 |
FY 2022 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2023 |
Q3 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
Q3 2023 |
Additional Paid in Capital |
213K |
USD |
-86.9% |
Q1 2023 |
Q1 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2023 |
Q3 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
5.51K |
USD |
0% |
Q4 2022 |
FY 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2023 |
Q3 2023 |